99 related articles for article (PubMed ID: 12910696)
1. [Relationship of the expression of CD44v6 and paxillin to the prognosis of non-small cell lung carcinoma].
Zuo W; Li H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):484-5. PubMed ID: 12910696
[TBL] [Abstract][Full Text] [Related]
2. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
3. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
Weng MX; Wu CH; Yang XP
Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
6. [Expression of MUC1, CD44v6, nm23 in gastric carcinomas and regional lymph node tissues and their association with invasion, metastasis, and prognosis of the tumor].
Li Y; Zhang JH; Kuang G; Yang JQ; Zhao Q; Wang XL; Jiao ZK; Zhang ZD; Wang LL
Ai Zheng; 2003 Sep; 22(9):985-9. PubMed ID: 12969535
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
8. [The expression of vascular endothelial growth factor, CD44v6 in non-small cell lung carcinoma].
Mei TH; Zhang GR; Ma Y
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):647-50. PubMed ID: 15329250
[TBL] [Abstract][Full Text] [Related]
9. [Expression of standard and variant CD44 in human lung cancer].
Zhao H; Fang J; Du G
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
[TBL] [Abstract][Full Text] [Related]
10. [Expression of CD44v6 and E-cadherin in prostate carcinoma and metastasis of prostate carcinoma].
Gu H; Shang P; Zhou C
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):32-4, 38. PubMed ID: 14979205
[TBL] [Abstract][Full Text] [Related]
11. [The relationship of expression of CD44v6 with metastasis and prognosis in breast cancer].
Deng Y; Ma W; Fang X; Zheng S
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):451-2. PubMed ID: 11832082
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of CD44(+)ESA(+)CD24(-/low), stem cell markers for breast cancer, in non-small-cell lung carcinoma].
Lu ZQ; Li HG; Zhang HZ; Fan MJ; Shen XM; He XX
Ai Zheng; 2008 Jun; 27(6):575-9. PubMed ID: 18570728
[TBL] [Abstract][Full Text] [Related]
13. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
14. [Expression of CD44 variant exon 6 in lung cancers].
Wang FL; Wei LX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):401-2. PubMed ID: 12940087
[TBL] [Abstract][Full Text] [Related]
15. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Salgia R; Li JL; Ewaniuk DS; Wang YB; Sattler M; Chen WC; Richards W; Pisick E; Shapiro GI; Rollins BJ; Chen LB; Griffin JD; Sugarbaker DJ
Oncogene; 1999 Jan; 18(1):67-77. PubMed ID: 9926921
[TBL] [Abstract][Full Text] [Related]
16. Significance of immunohistochemical over-expression of CD44v6 as an indicator of malignant potential in esophageal squamous cell carcinoma.
Nozoe T; Kohnoe S; Ezaki T; Kabashima A; Maehara Y
J Cancer Res Clin Oncol; 2004 Jun; 130(6):334-8. PubMed ID: 14872339
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cell adhesion molecule (CD44V6) in thyroid tumors and its significance].
Li L; Lin L; Qiu J
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):677-80. PubMed ID: 11769722
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.
Sun BS; Li Y; Zhang ZF; You J; Wang CL
Ann Thorac Surg; 2013 Dec; 96(6):1943-51. PubMed ID: 24094519
[TBL] [Abstract][Full Text] [Related]
20. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
